• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Life Sciences Ltd Miscellaneous

  • Indian Private
  • BSE Code : 4916.0
  • ISIN : INE495B01038
244.86 13 (5.82%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    232.31

  • Today’s High

    250.00

  • Open

    237.17

  • Perv Close

    231.40

  • 52W Low

    82.95

  • 52W High

    250.48

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    5,339.75

  • Div & Yield %

    0.00

  • Book Value(₹)

    36.66

  • Debt-Equity Ratio

    5.82

  • AGM Date

    30-May-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    5,339.75

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    21.81

  • BV (₹)

    36.70

  • Sales( ₹ in Cr.)

    6.66

  • NP (in Cr.)

    -47.08

  • NP Var(%)

    -135.0

  • Div%

    0.0

  • CPS (₹)

    -1.90

  • EPS (₹)

    -2.20

  • Traded Value (₹ in Lakhs)

    5,336.26

  • 52 Week High

    250.48

  • 52 Week Low

    82.95

  • Price BSE

    245.0

  • Price NSE

    245.00

  • Market Capital( in Cr.)

    5,336.26

  • P/C Ratio

    -129.50

  • P/E Ratio

    -113.50

  • Price Vs.BV

    -2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 11.69 13.54 11.84 13.48 14.41 285.67
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 11.69 13.54 11.84 13.48 14.41 285.67
Other Income 28.59 14.45 5.32 7.75 14.04 27.25
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 9.29
Total Income 40.28 27.99 17.16 21.23 28.45 322.21
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 79.62
Power and Fuel Cost 0.26 0.00 0.00 0.00 1.63 19.37
Employee Cost 16.53 15.77 17.46 15.29 14.60 33.85
Other Manufacturing Expenses 1.54 0.93 2.59 0.14 0.02 29.81
Selling and Administration Expenses 23.06 22.95 27.01 27.61 30.26 75.60
Miscellaneous Expenses 1.15 1.52 1.30 0.89 3.17 8.02
Employee Benefit Expenses 16.53 15.77 17.46 15.29 14.60 33.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 42.55 41.18 48.37 43.93 49.68 246.26
Operating Profit -2.27 -13.18 -31.22 -22.70 -21.23 75.94
Interest 0.24 0.40 0.64 0.91 0.54 1.90
Gross Profit -2.51 -13.58 -31.86 -23.61 -21.77 74.04
Depreciation 6.50 6.54 4.39 4.35 4.17 10.79
Profit Before Tax -9.01 -20.12 -36.25 -27.96 -25.94 63.25
Current Tax -1.00 0.00 0.00 0.38 2.28 12.99
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 -5.70 -14.46 11.07
Reported Net Profit -8.01 -20.13 -36.25 -22.63 -13.75 39.19
Extraordinary Items 12.01 7.79 3.99 0.06 0.50 12.89
Adjusted Net Profit -20.02 -27.92 -40.24 -22.69 -14.25 26.30
Adjustment below Net Profit -0.06 0.19 -0.15 -0.31 -0.30 -319.86
P & L Balance brought forward 141.49 161.43 197.83 220.77 234.82 515.49
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 133.43 141.49 161.43 197.83 220.77 234.82
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 150.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 1.50
Earnings Per Share-Unit Curr -0.37 -0.92 -2.49 -1.78 -1.08 3.08
Earnings Per Share(Adj)-Unit Curr -0.37 -0.92 -2.29 -1.64 -1.00 0.14
Book Value 38.77 39.14 32.74 28.66 30.46 31.56
Book Value(Adj)-Unit Curr 38.77 39.14 30.17 26.41 28.07 1.47

Shareholding Pattern

  • Promoter Group

    70.27%

  • Public Share Holding

    29.73%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,533,736 0.70 1,533,736 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 151,697,500 69.56 151,697,500 1
Others 0 0.00 0 0
Sub Total 153,231,236 70.27 153,231,236 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 100 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 547,382 0.25 547,382 14
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 20,298 0.01 2,298 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 400 0.00 400 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 568,180 0.26 550,180 19
2] Non Institution
Bodies Corporate 4,958,626 2.27 4,956,626 310
Clearing Members 0 0.00 0 0
Directors of their Relatives 325,637 0.15 325,637 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 4,075,732 1.87 4,075,732 1,226
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,182,874 1.00 2,182,874 1,221
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,476,185 3.89 8,476,185 14
Individuals holding nominal share capital up to Rs. 1 lakh 43,943,414 20.15 43,765,906 61,803
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 309,760 0.14 309,760 1
Sub Total 64,274,301 29.47 64,094,793 64,578
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 218,073,717 100.00 217,876,209 64,603

Company Background

Suven Life Sciences LtdMiscellaneous

  • Suven Life Sciences Ltd
  • BSE Code : 4916.0
  • ISIN : INE495B01038

  • Incorporation Year

    1989

  • Registered Office

    #8-2-334 SDE Serene Chambers
    6 th Floor Road No 5 Avenue 7, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23541142/3311/3315

  • FAX

    91-40-23541152

  • Chairman

    Venkateswarlu Jasti

  • Managing Director

  • Company Secretary

    Shrenik Soni

  • Auditor

    Karvy & Co

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Life Scie. 244.70 32.82 11.69 -113.29 -2.44
Apollo Hospitals 6,878.20 7,453.70 7,273.80 82.29 15.48
Kovai Medical 6,182.95 1,240.50 1,219.55 32.37 22.21
Vimta Labs 979.45 348.22 343.98 32.34 24.14
One Global Serv 250.35 63.01 63.01 9.63 77.53
Shree Pacetronix 81.60 22.17 22.04 17.14 34.41
Fortis Malar 75.72 67.88 59.01 344.18 -1.52
Medinova Diagno. 39.85 8.04 7.78 44.78 9.69
Chennai Meena 33.58 38.68 38.20 -11.78 0.00
Genesis IBRC 19.25 0.00 0.00 -160.42 0.00
Transgene Biotek 4.22 0.42 0.23 -46.89 0.00